Hain Celestial Looking For Deals As Net Cash Jumps, Portfolio Slims
Hain Celestial looks for acquisitions while continuing to pare down its portfolio as its North America business sales grew 3% to $280.7m in its latest quarter.
You may also be interested in...
CRN salutes former executive and influential nutritional ingredient researcher John Hathcock; AAHP tackles changing homeopathic industry regulation at first Summit; USANA appoints head of China business; supplements launch for brain health, hair growth and prenatal care.
Arcadia prohibited from arguing against Advantice’s appeal of National Advertising Division decision that Kerasal Fungal Nail Renewal ad claims weren’t supported. Arcadia violated confidentiality rule by publicizing NAD decision before the review was officially closed.
C&D CEO Matthew Farrell says Zicam has 73% share in the US zinc-containing wellness product market. It's acquiring marketer Matrixx Initiatives at a price almost 15 times Zicam brand’s projected 2021 EBITDA.